Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Anjin Group Inc
Profile last edited on: 7/22/08      CAGE: 4BJX5      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2002
First Award
2005
Latest Award
2008
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

10 Chillhowie Court
Cockeysville, MD 21030
   (443) 561-1434
   info@anjingroup.com
   www.anjingroup.com
Location: Single
Congr. District: 02
County: Baltimore

Public Profile

Anjin Group Inc has been granted a royalty-bearing worldwide license from the NIH that uses a toxin to treat cancers. The NIH is seeming to limit the use to treating cancer of the head and neck

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$567,216
Phase II Dollars
$0
Total Awarded
$567,216

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2008 1 NIH $122,830
Project Title: Generation Of A Modified Dt_il3 Fusion Toxin
2008 1 NIH $147,459
Project Title: Further Analysis Of A Vls Modified Il-2 Receptor Targeted Toxin
2006 1 NIH $152,141
Project Title: Modified Diphtheria Toxin IL-7 Fusion Toxins
2005 1 NIH $144,786
Project Title: An IL-2 Receptor Targeted Toxin with Reduced VLS

Key People / Management

  William S Harrison -- President

  Johanna C Vanderspek

Company News

There are no news available.